238 related articles for article (PubMed ID: 23486186)
1. Effects of pharmacological inhibition of cathepsin K on fracture repair in mice.
Soung do Y; Gentile MA; Duong LT; Drissi H
Bone; 2013 Jul; 55(1):248-55. PubMed ID: 23486186
[TBL] [Abstract][Full Text] [Related]
2. Increased fracture callus mineralization and strength in cathepsin K knockout mice.
Gentile MA; Soung do Y; Horrell C; Samadfam R; Drissi H; Duong LT
Bone; 2014 Sep; 66():72-81. PubMed ID: 24928497
[TBL] [Abstract][Full Text] [Related]
3. A novel role for cathepsin K in periosteal osteoclast precursors during fracture repair.
Walia B; Lingenheld E; Duong L; Sanjay A; Drissi H
Ann N Y Acad Sci; 2018 Mar; 1415(1):57-68. PubMed ID: 29479711
[TBL] [Abstract][Full Text] [Related]
4. The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking.
Leung P; Pickarski M; Zhuo Y; Masarachia PJ; Duong LT
Bone; 2011 Oct; 49(4):623-35. PubMed ID: 21718816
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model.
Saito M; Shiraishi A; Ito M; Sakai S; Hayakawa N; Mihara M; Marumo K
Bone; 2010 Apr; 46(4):1170-9. PubMed ID: 20026440
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis.
Hayami T; Zhuo Y; Wesolowski GA; Pickarski M; Duong LT
Bone; 2012 Jun; 50(6):1250-9. PubMed ID: 22484689
[TBL] [Abstract][Full Text] [Related]
7. An Ectosteric Inhibitor of Cathepsin K Inhibits Bone Resorption in Ovariectomized Mice.
Panwar P; Xue L; Søe K; Srivastava K; Law S; Delaisse JM; Brömme D
J Bone Miner Res; 2017 Dec; 32(12):2415-2430. PubMed ID: 28745432
[TBL] [Abstract][Full Text] [Related]
8. Odanacatib increases mineralized callus during fracture healing in a rabbit ulnar osteotomy model.
Pennypacker BL; Gilberto D; Gatto NT; Samadfam R; Smith SY; Kimmel DB; Duong le T
J Orthop Res; 2016 Jan; 34(1):72-80. PubMed ID: 26178170
[TBL] [Abstract][Full Text] [Related]
9. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats.
Cao Y; Mori S; Mashiba T; Westmore MS; Ma L; Sato M; Akiyama T; Shi L; Komatsubara S; Miyamoto K; Norimatsu H
J Bone Miner Res; 2002 Dec; 17(12):2237-46. PubMed ID: 12469918
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of bone resorption by the cathepsin K inhibitor odanacatib is fully reversible.
Zhuo Y; Gauthier JY; Black WC; Percival MD; Duong LT
Bone; 2014 Oct; 67():269-80. PubMed ID: 25038310
[TBL] [Abstract][Full Text] [Related]
11. Altered hematopoietic stem cell and osteoclast precursor frequency in cathepsin K null mice.
Jacome-Galarza C; Soung do Y; Adapala NS; Pickarski M; Sanjay A; Duong LT; Lorenzo JA; Drissi H
J Cell Biochem; 2014 Aug; 115(8):1449-57. PubMed ID: 24590570
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model.
Yee CS; Xie L; Hatsell S; Hum N; Murugesh D; Economides AN; Loots GG; Collette NM
Bone; 2016 Jan; 82():122-34. PubMed ID: 25952969
[TBL] [Abstract][Full Text] [Related]
13. Azanitrile Cathepsin K Inhibitors: Effects on Cell Toxicity, Osteoblast-Induced Mineralization and Osteoclast-Mediated Bone Resorption.
Ren ZY; Machuca-Gayet I; Domenget C; Buchet R; Wu Y; Jurdic P; Mebarek S
PLoS One; 2015; 10(7):e0132513. PubMed ID: 26168340
[TBL] [Abstract][Full Text] [Related]
14. Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing.
Gerstenfeld LC; Sacks DJ; Pelis M; Mason ZD; Graves DT; Barrero M; Ominsky MS; Kostenuik PJ; Morgan EF; Einhorn TA
J Bone Miner Res; 2009 Feb; 24(2):196-208. PubMed ID: 19016594
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy.
Mukherjee K; Chattopadhyay N
Biochem Pharmacol; 2016 Oct; 117():10-9. PubMed ID: 27106079
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of alendronate on fracture healing and bone remodeling of femoral shaft in ovariectomized rats.
Fu LJ; Tang TT; Hao YQ; Dai KR
Acta Pharmacol Sin; 2013 Mar; 34(3):387-92. PubMed ID: 23459092
[TBL] [Abstract][Full Text] [Related]
17. 1Alpha,25-dihydroxy-2beta(3-hydroxypropoxy)vitamin D3 (ED-71) suppressed callus remodeling but did not interfere with fracture healing in rat femora.
Cao Y; Mori S; Mashiba T; Kaji Y; Manabe T; Iwata K; Miyamoto K; Komatsubara S; Yamamoto T
Bone; 2007 Jan; 40(1):132-9. PubMed ID: 16962400
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial.
Bauer DC; Garnero P; Hochberg MC; Santora A; Delmas P; Ewing SK; Black DM;
J Bone Miner Res; 2006 Feb; 21(2):292-9. PubMed ID: 16418785
[TBL] [Abstract][Full Text] [Related]
19. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity.
Kayal RA; Tsatsas D; Bauer MA; Allen B; Al-Sebaei MO; Kakar S; Leone CW; Morgan EF; Gerstenfeld LC; Einhorn TA; Graves DT
J Bone Miner Res; 2007 Apr; 22(4):560-8. PubMed ID: 17243865
[TBL] [Abstract][Full Text] [Related]
20. Haploinsufficiency of endogenous parathyroid hormone-related peptide impairs bone fracture healing.
Wang YH; Qiu Y; Han XD; Xiong J; Chen YX; Shi HF; Karaplis A
Clin Exp Pharmacol Physiol; 2013 Nov; 40(11):715-23. PubMed ID: 23937065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
